Innate immunity in critical care

Seminars in Pediatric Infectious Diseases

Volumn 17, Issue 1, 2006, Pages 25-35

  Mariscalco, M Michele ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID; COTRIMOXAZOLE; GATAFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

AEROMONAS; AMEBIASIS; BACTERIAL INFECTION; CADAVER; CHOLERA; CLINICAL FEATURE; COMMUNICABLE DISEASE; CRYPTOSPORIDIOSIS; CYCLOSPORIASIS; DENGUE VIRUS; DIARRHEA; FOOD CONTAMINATION; GIARDIASIS; HEPATITIS A; HEPATITIS E; HUMAN; LEPTOSPIROSIS; MALARIA; MORBIDITY; MORTALITY; PARASITOSIS; PERSONAL HYGIENE; PSEUDOMONAS; RABIES VIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; ROTAVIRUS; SHIGELLOSIS; ST LOUIS FLAVIVIRUS; TUBERCULOSIS CONTROL; TYPHOID FEVER; WATER CONTAMINATION; WEST NILE FLAVIVIRUS; WOUND COMPLICATION;

EID: 33644745324     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.spid.2005.11.007     Document Type: Article

References (77)

1. R. Medzhitov, C. Janeway Innate immunity N Engl J Med 343 2000 338 344
2. G.R. Bernard, J.L. Vincent, P.F. Laterre Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709
3. C.A. Janeway Jr, R. Medzhitov innate immune recognition Annu Rev Immunol 20 2002 197 216
4. J. Lu, C. Teh, U. Kishore Collectins and ficolins sugar pattern recognition molecules of the mammalian innate immune system Biochim Biophys Acta 1572 2002 387 400
5. M.B. Pepys, G.M. Hirschfield C-reactive protein a critical update J Clin Invest 111 2003 1805 1812
6. M.J. Walport Complement. First of two parts N Engl J Med 344 2001 1058 1066
7. C.A. Janeway Jr A trip through my life with an immunological theme Annu Rev Immunol 20 2002 1 28
8. G. Baumgarten, P. Knuefermann, N. Nozaki In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration the role of toll-like receptor-4 J Infect Dis 183 2001 1617 1624
9. B. Beutler Inferences, questions and possibilities in Toll-like receptor signalling Nature 430 2004 257 263
10. S. Mukhopadhyay, J. Herre, G.D. Brown The potential for Toll-like receptors to collaborate with other innate immune receptors Immunology 112 2004 521 530
11. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395
12. M.F. Tsan, B. Gao Endogenous ligands of Toll-like receptors J Leukoc Biol 76 2004 514 519
13. M. Levin, P.A. Quint, B. Goldstein rBPI21 Meningococcal Sepsis Study Group Recombinant bactericidal/permeability- increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis a randomised trial Lancet 356 2000 961 967
14. O. Bohana-Kashtan, L. Ziporen, N. Donin Cell signals transduced by complement Mol Immunol 41 2004 583 597
15. R.F. Guo, P.A. Ward Role of C5a in inflammatory responses Annu Rev Immunol 23 2005 821 852
16. B.J. Czermak, V. Sarma, C.L. Pierson Protective effects of C5a blockade in sepsis Nat Med 5 1999 788 792
17. M. Huber-Lang, V.J. Sarma, K.T. Lu Role of C5a in multiorgan failure during sepsis J Immunol 166 2001 1193 1199
18. M.L. Hart, M.C. Walsh, G.L. Stahl Initiation of complement activation following oxidative stress. In vitro and in vivo observations Mol Immunol 41 2004 165 171
19. C.B. Granger, K.W. Mahaffey, W.D. Weaver Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial Circulation 108 2003 1184 1190
20. E.D. Verrier, S.K. Shernan, K.M. Taylor Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass a randomized trial JAMA 291 2004 2319 2327
21. Z. Shariat-Madar, A.H. Schmaier The plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsis J Endotoxin Res 10 2004 3 13
22. A. Ueno, S. Oh-ishi Roles for the kallikrein-kinin system in inflammatory exudation and pain lessons from studies on kininogen-deficient rats J Pharmacol Sci 93 2003 1 20
23. M. Cyr, T. Eastlund, C. Blais Jr Bradykinin metabolism and hypotensive transfusion reactions Transfusion 41 2001 136 150
24. D.M. Arnold, G. Molinaro, T.E. Warkentin Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage Transfusion 44 2004 1361 1366
25. G.A. Zimmerman, T.M. McIntyre, S.M. Prescott The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis Crit Care Med 30 2002 S294 S301
26. S. Opal, P.F. Laterre, E. Abraham Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial Crit Care Med 32 2004 332 341
27. A. Zlotnik, O. Yoshie Chemokines a new classification system and their role in immunity Immunity 12 2000 121 127
28. C.J. Fisher Jr, J.F. Dhainaut, S.M. Opal Phase III rhIL-lra Sepsis Syndrome Study Group Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial JAMA 271 1994 1836 1843
29. S.M. Opal, C.J. Fisher Jr, J.F. Dhainaut The Interleukin-1 Receptor Antagonist Sepsis Investigator Group Confirmatory interleukin-1 receptor antagonist trial in severe sepsis a phase III, randomized, double-blind, placebo-controlled, multicenter trial Crit Care Med 25 1997 1115 1124
30. E. Abraham, A. Anzueto, G. Gutierrez NORASEPT II Study Group Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock Lancet 351 1998 929 933
31. E.A. Panacek, J.C. Marshall, T.E. Albertson Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels Crit Care Med 32 2004 2173 2182
32. E. Abraham, P.F. Laterre, J. Garbino Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients Crit Care Med 29 2001 503 510
33. G. Grass, E.A. Neugebauer Afelimomab-another therapeutic option in sepsis therapy? Crit Care Med 32 2004 2343 2344
34. H. Wang, O. Bloom, M. Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
35. H. Yang, M. Ochani, J. Li Reversing established sepsis with antagonists of endogenous high- mobility group box 1 Proc Natl Acad Sci USA 101 2004 296 301
36. M.T. Lotze, K.J. Tracey High-mobility group box 1 protein (HMGB1) nuclear weapon in the immune arsenal Nat Rev Immunol 5 2005 331 342
37. M. Bozza, A.R. Satoskar, G. Lin Ta disruption of migration inhibitory factor gene reveals its critical role in sepsis 189 1999 341 346
38. F.A. Bozza, R.N. Gomes, A.M. Japiassu Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis Shock 22 2004 309 313
39. L.E. Lehmann, S.U. Weber, D. Fuchs Intracellular detection of macrophage migration inhibitory factor in peripheral blood leukocytes Free Radic Biol Med 38 2005 1170 1179
40. F. Wang, F. Gao, L. Jing Is macrophage migration inhibitory factor (MIF) the "control point" of vascular hypo-responsiveness in septic shock? Med Hypotheses 2005
41. T. Calandra, T. Roger Macrophage migration inhibitory factor a regulator of innate immunity Nat Rev Immunol 3 2003 791 800
42. Y. Ren, C.L. Lin, Z. Li Up- regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis Histopathology 46 2005 659 667
43. J.O. Lundberg, T. Farkas-Szallasi, E. Weitzberg High nitric oxide production in human paranasal sinuses Nat Med 1 1995 370 373
44. M. Deja, T. Busch, S. Bachmann Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis Am J Respir Crit Care Med 168 2003 281 286
45. J.E. Blalock The immune system as the sixth sense J Intern Med 257 2005 126 138
46. K.J. Tracey The inflammatory reflex Nature 420 2002 853 859
47. L.V. Borovikova, S. Ivanova, M. Zhang Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin Nature 405 2000 458 462
48. H. Wang, M. Yu, M. Ochani Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation Nature 421 2003 384 388
49. D.J. van Westerloo, I.A. Giebelen, S. Florquin The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis J Infect Dis 191 2005 2138 2148
50. R.W. Saeed, S. Varma, T. Peng-Nemeroff Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation J Exp Med 201 2005 1113 1123
51. H.W. Yien, S.S. Hseu, L.C. Lee Spectral analysis of systemic arterial pressure and heart rate signals as a prognostic tool for the prediction of patient outcome in the intensive care unit Crit Care Med 25 1997 258 266
52. S. Zeerleder, C.E. Hack, C. Caliezi Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction Clin Immunol 116 2005 158 165
53. A.S. Weyrich, G.A. Zimmerman Platelets signaling cells in the immune continuum Trends Immunol 25 2004 489 495
54. S.D. Douglas, R. Kapur, J.D. Merrill The mononuclear phagocytic, dendritic cell, and natural killer cell systems E.R. Stiehm H.D. Ochs J.A. Winkelstein Immunologic Disorders in Infants and Children 2004 Elsevier Saunders Philadelphia PA 129 156
55. M.C. Dinauer, J.A. Lekstrom-Himes, D.C. Dale Inherited neutrophil disorders molecular basis and new therapies Hematology 2000 303 318
56. T.A. Springer Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration Annu Rev Physiol 57 1995 827 872
57. H. Jaeschke, C.W. Smith Cell adhesion and migration. III. Leukocyte adhesion and transmigration in the liver vasculature Am J Physiol 273 1997 G1169 G1173
58. M.M. Mariscalco Integrins and cell adhesion molecules R.A. Polin W.W. Fox S.H. Abman Fetal and Neonatal Physiology 2004 Elsevier Saunders Philadelphia, PA 1572 1591
59. A.R. Burns, C.W. Smith, D.C. Walker Unique structural features that influence neutrophil emigration into the lung Physiol Rev 83 2003 309 336
60. K. Singbartl, K. Ley Leukocyte recruitment and acute renal failure J Mol Med 82 2004 91 101
61. K. Yonekawa, J.M. Harlan Targeting leukocyte integrins in human diseases J Leukoc Biol 77 2005 129 140
62. R. Badolato Leukocyte circulation one-way or round-trip? Lessons from primary immunodeficiency patients J Leukoc Biol 76 2004 1 6
63. A.D. Chishti, B.K. Shenton, J.A. Kirby Neutrophil chemotaxis and receptor expression in clinical septic shock Intensive Care Med 30 2004 605 611
64. N.A. Ahmed, S. McGill, J. Yee Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis) Crit Care Med 27 1999 2459 2468
65. G.E. Brown, G.M. Silver, J. Reiff Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries J Trauma 46 1999 297 305
66. J. Braun, M. Pein, H. Djonlagic Production of reactive oxygen species by central venous and arterial neutrophils in severe pneumonia and cardiac lung edema Intensive Care Med 23 1997 170 176
67. M.F. Jimenez, R.W. Watson, J. Parodo Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome Arch Surg 132 1997 1263 1269
68. K. Tschaikowsky, M. Hedwig-Geissing, A. Schiele Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis longitudinal study of mononuclear histocompatibility leukocyte antigen- DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients Crit Care Med 30 2002 1015 1023
69. M.L. Allen, M.J. Peters, A. Goldman Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care Crit Care Med 30 2002 1140 1145
70. M. Weiss, G. Fischer, E. Barth Dissociation of LPS-induced monocytic ex vivo production of granulocyte colony- stimulating factor (G-CSF) and TNF-alpha in patients with septic shock Cytokine 13 2001 51 54
71. T.I. Sorensen, G.G. Nielsen, P.K. Andersen Genetic and environmental influences on premature death in adult adoptees N Engl J Med 318 1988 727 732
72. M.K. Dahmer, A. Randolph, S. Vitali Genetic polymorphisms in sepsis Pediatr Crit Care Med 6 2005 S61 S73
73. J.L. Vincent, Q. Sun, M.J. Dubois Clinical trials of immunomodulatory therapies in severe sepsis and septic shock Clin Infect Dis 34 2002 1084 1093
74. J.L. Vincent, S. Nadel, D.J. Kutsogiannis Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease a retrospective analysis of patients enrolled in recent clinical studies Crit Care 9 2005 R331 R343
75. K. Hubel, D.C. Dale, W.C. Liles Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases current status of granulocyte colony- stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma1 J Infect Dis 185 2002 1490 1501
76. R. Carr, N. Modi, C. Dore G-CSF and GM-CSF for treating or preventing neonatal infections Cochrane Database Syst Rev CD003066 2003
77. L.M. Napolitano Immune stimulation in sepsis to be or not to be? Chest 127 2005 1882 1885